Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

Round two DMEPOS competitive bidding launched July 1 despite efforts by durable medical equipment makers and suppliers to delay it. OIG reports to CMS on continuous positive airway pressure supplies and therapeutic shoes. More reimbursement news.

You may also be interested in...



Reimbursement Briefs: AMA Wants ICD-10 Halt; News From CMS, AHRQ And OIG

AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.

News Briefs: MAKO Purchase; KCI Merger; Medicare Competitive Bidding Update

MAKO plans to acquire Pipeline Biomedical Holdings before it becomes part of Stryker. KCI, LifeCell and Systagenix to merge. Medicare announces rates for DME competitive bidding recompete. More news.

Reimbursement Briefs: OIG Looks At DME; AHRQ Seeks Imaging Info; MolDx News

OIG announces investigation of Medicare’s competitive bidding program in four states and, separately, finds inappropriate and questionable CMS billing for diabetes test strips. AHRQ seeks information about imaging tests for diagnosis and staging of pancreatic cancer. More reimbursement news.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel